Showing results (571-580 of 3,020) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|November 3, 2016
Glyco-Engineering of Human IgG-Fc to Modulate Biologic ActivitiesRoy JefferisCurrent Pharmaceutical Biotechnology|January 7, 2017
Antimicrobial Effectiveness of Bioactive Silver Nanoparticles Synthesized by Actinomycetes HGG16n StrainBogusław Buszewski, Viorica Railean-Plugaru, Pawel Pomastowski, et al.Current Pharmaceutical Biotechnology|April 1, 2014
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitationsRuchita S Selot, Sangeetha Hareendran, Giridhara R JayandharanCurrent Pharmaceutical Biotechnology|April 12, 2014
Is glyburide safe in pregnancy?Żaneta Kimber-Trojnar, Beata Marciniak, Jolanta Patro-Malysza, et al.Current Pharmaceutical Biotechnology|April 12, 2014
Polyunsaturated fatty acids in pregnancy and metabolic syndrome: a reviewElzbieta Poniedzialek-Czajkowska, Radzislaw Mierzynski, Zaneta Kimber-Trojnar, et al.Current Pharmaceutical Biotechnology|April 12, 2014
The impact of substance P on the pathogenesis of insulin resistance leading to gestational diabetesJolanta Patro-Malysza, Zaneta Kimber-Trojnar, Katarzyna Skorzynska-Dziduszko, et al.Current Pharmaceutical Biotechnology|February 22, 2008
MicroRNAs in tumorigenesisKai Ove Skaftnesmo, Lars Prestegarden, David R Micklem, et al.Current Pharmaceutical Biotechnology|February 22, 2008
Bcl-2 antisense in the treatment of human malignancies: a delusion in targeted therapyBjørn Tore Gjertsen, Therese Bredholt, Nina Anensen, et al.Current Pharmaceutical Biotechnology|February 22, 2008
Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cellØ Bruserud, C Stapnes, E Ersvaer, et al.Current Pharmaceutical Biotechnology|February 22, 2008
Epigenetic targeting in acute myeloid leukemia: use of flow cytometry in monitoring therapeutic effectsAnita Ryningen, Øystein BruserudPageof 302